Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
第一作者:
Aaron,Brant
第一单位:
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD. Electronic address: abrant@jhmi.edu.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 移行细胞(Carcinoma, Transitional Cell);化学疗法, 辅助(Chemotherapy, Adjuvant);顺铂(Cisplatin);膀胱切除术(Cystectomy);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肌, 平滑(Muscle, Smooth);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤侵润(Neoplasm Invasiveness);肿瘤分期(Neoplasm Staging);回顾性研究(Retrospective Studies);存活率(Survival Rate);治疗结果(Treatment Outcome);肿瘤负荷(Tumor Burden);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1016/j.urolonc.2016.08.005
PMID
27639777
发布时间
2018-04-16
- 浏览61

Urologic oncology
34.e17-34.e25页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文